Search Results for keywords:"GE Healthcare"

Found 2 results

Search Results: keywords:"GE Healthcare"

💰 Only
Oldest Newest
  • 2021-00353 — Importer of Controlled Substances Application: Medi-Physics, Inc. dba GE Healthcare
    Type:Notice
    Citation:86 FR 2456
    Reading Time:about a minute or two

    Medi-Physics, Inc., which does business as GE Healthcare, has submitted an application to the Drug Enforcement Administration (DEA) to become an importer of specific controlled substances. The company intends to import small amounts of Ioflupane, which is an analogue of Cocaine, for research and development purposes, as the required form is unavailable in the U.S. Anyone wishing to comment or request a hearing on this application must do so by February 11, 2021. The DEA's approval will depend on compliance with specific regulatory standards.

    Simple Explanation

    Medi-Physics, Inc., also known as GE Healthcare, wants to bring a special kind of medicine ingredient, related to Cocaine, from outside the U.S. because they can't get it here. They need it to work on how to make and check their products properly, and people can share their thoughts or concerns about this until February 11, 2021.

  • 2025-02014 — Importer of Controlled Substances Application: Medi-Physics Inc. DBA GE Healthcare
    Type:Notice
    Citation:90 FR 8718
    Reading Time:about a minute or two

    Medi-Physics Inc., doing business as GE Healthcare, has applied to register as an importer of certain controlled substances. They plan to use these substances for making a diagnostic product and reference standards but have not been authorized for other activities involving these substances. The public can submit comments or objections electronically by March 3, 2025, through the Federal eRulemaking Portal. Requests for a hearing on this application must also be submitted by the same date to the Drug Enforcement Administration.

    Simple Explanation

    Medi-Physics Inc., also known as GE Healthcare, wants permission to bring special medicines into the US to help make health tests. The public can say what they think about this by March 3, 2025.